A large number of hospitalized patients have an indwelling urinary tract catheter (IUC) placed at some time during their hospital stay and may suffer from catheter-associated urinary tract infections, the leading cause of nosocomial infections. Here we investigated the prevalence of uropathogens associated with catheter-associated urinary tract infections and assessed the resistances of these pathogens to commonly prescribed antibiotics. In total, 2,997 urine samples were examined at a regional hospital in Taipei, Taiwan in 2004: 1,948 (65%) samples from hospitalized patients and 1,049 (35%) samples from outpatients. Patients with IUCs accounted for 1,381 samples (46%). Stratified analyses were used to calculate the age-and gender-adjusted odds ratio (OR) of antimicrobial resistance associated with the use of IUCs. Compared to the urine specimens of the patients without IUCs, those isolated from catheterized patients had a lower prevalence rate of Escherichia (E.) coli (23.4% vs 36.8%) and higher rates of resistant strains including Pseudomonas species (16.4% vs 8.6%) and rare gram-negative bacilli (5.8% vs 4.5%). Additionally, IUCs significantly increased the antimicrobial resistance of E. coli (OR 2.41-3.07), other species of Enterobacteriaceae (OR 1.57-2.38), and rare gram-negative bacilli (OR 2.41-5.21) to nearly all antibiotics tested, such as trimethoprim/sulfamethoxazole. Thus, IUCs increased the prevalence of urinary tract infections caused by some highly resistant pathogens. Moreover, IUCs were associated with the increased risk of concurrent resistance of Enterobacteriaceae. Clinicians are advised to exercise better management of urinary catheter in order to further reduce and control catheter-associated urinary tract infections in hospitals.
ceptibility testing reports in 2004 retrieving from a 500-bed regional teaching hospital in Taipei, Taiwan. Frequency distributions of uropathogens and prevalence rates of antimicrobial resistance to the tested antibiotics were calculated in relation to the use of IUCs. Access to the laboratory data was reviewed and approved by the Taipei City Hospital Ethics Committee.
Bacterial cultures and antimicrobial susceptibility testing
Quantitative analyses of urine cultures were performed using the standard calibrated loop method. A urine sample was streaked on a split plate with half sheep blood agar and half Mac Conkey agar. After incubation at 37°C for 24 hrs, the microorganisms were identified using standard biochemical tests. All specimens with bacteriuria of > 10 5 colony-forming units per milliliter (CFU/ml) of 1 or 2 organisms were analyzed to determine the causative pathogens and their antimicrobial resistance. If 3 or more types of organisms were present, the result was regarded as mixed growth, and the antimicrobial susceptibility was not tested. Antimicrobial susceptibility testing was performed by using the disk diffusion method (BBL Sensi-Disc; BD, Franklin Lakes, NJ, USA), following the guidelines of the Clinical and Laboratory Standards Institute (Bauer et al. 1966; Clinical and Laboratory Standards Institute 2003) . Gram-negative bacilli (GNB) were classified into the following categories: E. coli, non-E. coli Enterobacteriaceae (NECE), Pseudomonas spp., and rare gram-negative bacilli (RGNB). NECE included Proteus spp., Klebsiella spp., Morganella spp., Enterobacter spp., Providencia spp., Serratia spp., Citrobacter spp., and Salmonella spp. RGNB included Acinetobacter spp., Alcaligenes spp., Stenotrophomonas spp., Burkhoderia spp., and Chryseobacter spp.
Both E. coli and NECE were tested against trimethoprim/sulfamethoxazole (SXT), cefazolin, c o -a m o x i c l a v, c i p r o fl o x a c i n , a n d g e n t a m i c i n . Pseudomonas spp. and RGNB were tested against ciprofloxacin, gentamicin, amikacin, and ceftazidime. Concurrent resistance analyses were conducted for SXTresistant Enterobacteriaceae (including E. coli and NECE), and the rates of concurrent resistance to other tested antibiotics were calculated.
Statistical analysis
For exclusion of possible duplication, the same pathogen from the same patient with an identical resistance pattern was excluded from the calculations of the frequency distribution of uropathogens and of the prevawere estimated at 5% per day and 21% per month, respectively (Garibaldi et al. 1974; Ouslander et al. 1987) . Catheter-associated urinary tract infections (CAUTIs) have been reported to be the leading cause of nosocomial infections, and they may account for some 40% of all infections in hospitals (Haley et al. 1981 (Haley et al. , 1985 Patel and Arya 2000) . Additionally, the frequency distribution of pathogens causing CAUTIs might differ from that of pathogens isolated from patients without IUCs. Empirical antimicrobial treatment is usually begun when a symptomatic CAUTI is suspected but the result of a urine culture is not yet available. Determining the uropathogens that cause CAUTIs and the resistance of these uropathogens to commonly prescribed antibiotics is clinically essential, and would be helpful in improving the efficacy of empirical treatment.
Some previous studies investigated whether the species of pathogens associated with CAUTIs and their antimicrobial resistance may differ from those isolated from patients without IUCs; however, the results were inclusive (Bonadio et al. 2001; Wazait et al. 2003) . In addition, other investigations also reported that the prevalence of antimicrobial resistance might vary with certain patients' demographic characteristics, such as gender, age, and geographic region (Bonadio et al. 2001; Gupta et al. 2001a; Sahm et al. 2001; Sotto et al. 2001) . To the best of our knowledge, data on local antimicrobial resistance for uropathogens in Taiwan are available from only 2 studies (Hsueh et al. 2002; McDonald et al. 2002) . This study, using 2004 annual data from a 500-bed regional teaching hospital in Taipei City, Taiwan, attempted to investigate the species of pathogens associated with UTIs and their resistance to commonly prescribed antibiotics. Results from this analysis may prove useful as a guide to the empirical treatment of CAUTIs in the study region, and they may also provide a basis for comparison with other studies.
METHODS

Design and setting
This was a cross-sectional survey with laboratory data on uropathogens and their in vitro antimicrobial sus-lence of antimicrobial resistance. The distribution frequency of uropathogens was calculated according to whether the IUCs were used. Stratified analyses were performed to assess the significance of the effect-modification by age and gender of patients on the antimicrobial resistance. The homogeneity of age-and gender-specific ORs was assessed using the method of Breslow and Day (1980) , with the Mantel-Haenszel inference applied to estimate the common OR after adjusting for patient age and gender. StatXact software vers. 5.0 (Cytel Software Corporation, Cambridge, MA, USA) was used for the analysis, with a two-sided p < 0.05 considered statistically significant.
RESULTS
Uropathogen distribution
In total, 2,997 urine samples were examined by the hospital microbiological laboratory in a Three or more pathogens were cultured from the same urine specimen. 2004. Of these, 1,948 (65%) samples were from hospitalized patients, and 1,049 (35%) samples were from outpatients. Patients with IUCs accounted for 1,381 samples (46%). The results of urine culture revealed distribution frequencies for none, 1 pathogen, 2 pathogens, and mixed growth of 26.2%, 51.7%, 17.5%, and 4.6%, respectively, for patients with IUCs and corresponding frequencies of 36.6%, 48.2%, 11.5%, and 3.7% for their non-catheterized counterparts. After subtracting 54 possible duplications from the 2,347 pathogens isolated from the urine samples with 1 or 2 pathogens, 2,293 pathogens were analyzed for uropathogen distribution frequency and for in vitro antimicrobial resistance examination. Of these, 1,168 and 1,125 pathogens were isolated from patients with and without IUCs, respectively (Table 1) .
There was a significant difference in prevalence of various uropathogens between patients with IUCs and non-catheterized patients. Escherichia coli (36.8%) was the most prevalent pathogen in non-catheterized patients, followed by NECE (19.2%), Pseudomonas spp. (8.6%), and Enterococcus spp. (7.3%). In catheterized patients, E. coli (23.4%) was still the most prevalent uropathogen, followed by NECE (20.5%), Pseudomonas spp. (16.4%), and RGNB (5.8%). Compared to non-catheterized patients, catheterized patients tended to have a lower prevalence of E. coli but higher prevalence rates of Pseudomonas spp. and RGNB (Table 2 ). There was no significant difference in the prevalence of NECE strains individually or collectively between the catheterized and non-catheterized patients (data not shown in table).
After stratification by age and gender, the numbers of strains among GNB with complete data of antimicrobial susceptibility tests according to the use of IUCs are presented in Table 3 . E. coli was more prevalent in female patients than in males, whereas, male patients experienced higher prevalence of NECE and Pseudomonas spp. Such observation was independent of the use of IUCs.
Prevalence of antimicrobial resistance
The overall prevalence and age-and gender- The prevalence of resistance to all tested antimicrobials was consistently and significantly higher for NECE isolated from catheterized patients than for NECE from non-catheterized patients. The highest antimicrobial resistance OR was observed for SXT (OR = 2.38) followed by ciprofloxacin (OR = 2.05). The lowest OR of antimicrobial resistance was observed for co-amoxiclav (OR = 1.57).
The use of IUCs appeared to be associated with a slightly increased OR of antimicrobial resistance for Pseudomonas spp. to all tested anti- biotics; however, the increases in prevalence are not statistically significant. The prevalence rates of antimicrobial resistance were generally high for RGNB. In noncatheterized patients, the prevalence ranged from 51.1% for ceftazidime to 74.5% for gentamicin. IUCs were found to significantly increase the prevalence of antimicrobial resistance to all tested antibiotics except amikacin, with the highest and lowest ORs noted for gentamicin (OR = 5.21) and ceftazidime (OR = 2.66), respectively.
We further assessed interactions among different groups of age and gender, and noted that neither age nor gender posed a significant effect on modifying the relationship between the use of IUCs and the increased risks of antimicrobial resistance to all tested antibiotics for all studied pathogens (data not shown in table).
Concurrent resistance of the Enterobacteriaceae
The prevalence and OR of concurrent resistance to SXT and various tested antibiotics for Enterobacteriaceae are shown in Table 5 . For the Enterobacteriaceae pathogens resistant to SXT, it is common that they also had concurrent resistance to cefazolin, co-amoxiclav, ciprofloxacin, and gentamicin. Furthermore, IUCs were observed to even increase significantly the risk of concurrent resistance with OR ranging from 1.71 (concurrent resistance to gentamicin) to 2.55 (concurrent resistance to cefazolin).
DISCUSSION
More than 60% of urine specimens from our sampled individuals without IUCs were tested positive (bacteriuria of > 10 5 CFU/ml with 1 or 2 organisms). This positive rate was higher than those reported in some previous studies. In fact, there is inconsistency among studies for the positive rate in uncomplicated UTI patients (Kahlmeter 2003; Akram et al. 2007 ). Differences in study design and in the definition of bacteriuria may have contributed to such inconsistencies. Additionally, the current management of uncomplicated community-acquired UTIs is usually pragmatic, not based on a urine culture or susceptibility testing to guide therapy (Gupta et al. 2001b ). Urine culturing is reserved for patients without a good response to empirical antimicrobial treatment. The difference in clinical practice in managing urinary tract infections may also be another possible reason for the observed difference in the results of urine culture.
In our study, the use of IUCs was associated with a frequency distribution of uropathogen species distinct from that of non-catheter-related infections. First, although E. coli remained the most common pathogen in catheterized patients, its prevalence was lower compared to that found in non-catheterized patients (23.4% vs 36.8%). Second, the prevalence rates of Pseudomonas spp. and RGNB were higher in catheterized patients (8.6% vs 16.4% and 4.5% vs 5.8%, respectively). The denominator is the number of total stains in the category, and the numerator is the number of resistant strains. b ** p < 0.01; *** p < 0.001.
Using data from a UK hospital laboratory from 1996 to 2001, Wazait et al. (2003) estimated that the prevalence rates of E. coli and Pseudomonas spp. in catheterized patients were 26.6% and 10.8%, respectively. Bonadio et al. (2001) reported analogous rates of 30% and 24%. After subtracting Candida spp. from the total isolates in our study, the prevalence of E. coli and Pseudomonas spp. among CAUTIs was 29.8% and 20.9%, respectively. The prevalence of E. coli was quite similar to those reported in the above-mentioned two studies, while the prevalence of Pseudomonas spp. was higher than that reported by Wazait et al. (2003) . Wazait et al. (2003) defined CAUTI as bacteriuria of > 10 3 CFU/ml of 1 or 2 organisms. Differences in the definition of bacteriuria might be responsible for the difference in frequency distribution. Our data showed that IUCs were associated with increased risk of UTIs caused by highly resistant bacteria, such as Pseudomonas spp. or RGNB. In addition, the prevalence of Candida spp. was much higher in catheterized specimens. Patients with IUCs tend to have pyuria or UTIs (Garibaldi et al. 1974; Ouslander et al. 1987) , and the selective antimicrobial pressure on urinary bacteria may promote the growth of resistant strains (Schaeffer 2000) as well as Candida spp. (Paul et al. 2007 ).
In our study, 35% of urine specimens were obtained from outpatients. Inclusion of outpatients might have influenced the frequency distribution and antimicrobial resistance patterns of the uropathogens. Most community-acquired uncomplicated UTIs in women are caused by E. coli (Gupta et al. 2001b) . As a result, our study showed a higher percentage of E. coli in noncatheterized female patients, especially those aged 0-65 years. With regard to antimicrobial resistance, Bonadio et al. (2001) reported an increased, but insignificant, prevalence of resistance to ampicillin, fluoroquinolone, and SXT for E. coli isolated from inpatients compared to outpatients. Based on the observation by Bonadio et al. (2001) , inclusion of outpatients in this study would pose little influence on estimated prevalence of antimicrobial resistance.
The prevalence of resistance to SXT in E. coli was high in our study, especially in patients with IUCs (69.9%). The resistance rates reported by Wazait et al. (2003) and Bonadio et al. (2001) were 35.8% and 35.5%, respectively. In a study conducted by McDonald et al. (2002) in Taiwan in 2000, resistance to SXT in E. coli isolated from urine specimens was 62%. Data from our study and that conducted by McDonald et al. (2002) suggest a higher prevalence of SXT resistance of E. coli from Taiwanese patients. However, more investigations, incorporating patients from other parts of Taiwan, are needed to confirm the above observation in terms of national significance.
In our study, the prevalence of resistance to ciprofloxacin in E. coli was much higher than the rates of resistance to cefazolin and co-amoxiclav. In addition, IUCs further increased the risk of resistance to ciprofloxacin by 3.07-fold. Good antimicrobial susceptibility has been reported for ciprofloxacin against E. coli (3%-10% resistance prevalence) (Garau et al. 1999; Sotto et al. 2001) . By contrast, a higher ciprofloxacin resistance prevalence (about 20%) has been reported in E. coli isolated from urine samples from hospitalized patients (Ena et al. 1998; Gales et al. 2000) . Ena et al. (1998) reported a significant increase in ciprofloxacin resistance in E. coli isolated from urine samples resulting from an increase of fluoroquinolone consumption. Such a relationship might be a possible explanation for the high prevalence of ciprofloxacin resistance in E. coli noted in the present investigation.
Certain RGNB (e.g., Acinetobacter baumannii) are highly resistant to antibiotics and are responsible for complicated UTIs and opportunistic infections in immune-compromised patients (Sobel and Kaye 1995; Spicer 2000) . In our study, the prevalence of resistance to all tested antibiotics was high for RGNB, with IUCs conferring further significant increases in the risk of resistance to these antibiotics. The higher frequency distribution of RGNB isolated from catheterized urine samples, compared to non-catheterized samples, and their high prevalence of resistance to the antibiotics tested raise concerns over difficulties in the treatment of CAUTIs.
In this study, concurrent resistance of Enterobacteriaceae to SXT and various tested antibiotics was quite obvious. The highest prevalence of concurrent resistance was noted for cefazolin, followed, in descending order, by gentamicin, co-amoxiclav, and ciprofloxacin. IUCs may also increase the risk of concurrent resistance to all tested antibiotics. Mazzulli (2001) reported prevalence of concurrent resistance of 75.6% for ampicillin and 0% for ciprofloxacin in SXTresistant bacteria. Sahm et al. (2001) reported that ampicillin, SXT, and cephalothin were the most common combination of antimicrobials with concurrent resistance in E. coli. Our results are similar to the findings of previous studies with regard to the concurrent resistance to cefazoline and co-amoxiclav in SXT-resistant Enterobacteriaceae. However, unlike the low prevalence rate reported in those previous, the prevalence of concurrent resistance to ciprofloxacin was relatively high in our study.
In patients with IUCs, urinary bacteria are likely to form a biofilm protecting them from eradication by antibiotics (Cox et al. 1989) . Persistent colonization of IUCs, together with antimicrobial exposure without effective killing, promotes the emergence of resistant strains. Bacteria with elevated resistance to antimicrobials may develop in 2 ways. There may be a higher prevalence of acquired resistance in the usual uropathogens, such as E. coli or Klebsiella spp., to first-line agents, including ampicillin, co-trimoxazole, and the fluoroquinolones. On the other hand, organisms with a greater intrinsic resistance to antimicrobials may be isolated more frequently (Nicolle 2002) .
In conclusion, this study demonstrated that indwelling urinary catheters not only increased the prevalence of UTIs caused by highly resistant pathogens such as Pseudomonas spp. and RGNB, but also increased the risks of antimicrobial resistance and of concurrent resistance in the Enterobacteriaceae. Clinicians are advised to exercise better management of urinary catheter in order to further reduce and control CAUTIs in hospitals.
